These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 6191712)

  • 1. [Optimal administration schedules of antineoplastic antibiotics based on their pharmacokinetics, with special reference to bleomycins and anthracyclines].
    Ota K; Goto T; Fukushima M; Ariyoshi Y
    Gan To Kagaku Ryoho; 1982 Aug; 9(8):1352-61. PubMed ID: 6191712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Continuous venous infusion in cancer chemotherapy].
    Ota K
    Gan To Kagaku Ryoho; 1985 Apr; 12(4):798-805. PubMed ID: 2580486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental and clinical studies on aclarubicin in the treatment of solid tumors.
    Kumai K; Kubota T; Ishibiki K; Abe O
    Biomed Pharmacother; 1984; 38(7):332-7. PubMed ID: 6596963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent studies on antibiotics and small molecular immunomodulators with potential usefulness in treating lung cancer: Part I - Antitumor antibiotics and their derivatives.
    Umezawa H
    Int J Clin Pharmacol Ther Toxicol; 1982 Jan; 20(1):12-8. PubMed ID: 6173340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of peplomycin by continuous infusion on Ehrlich carcinoma].
    Kato T; Mizutani M; Ota K
    Gan To Kagaku Ryoho; 1983 Mar; 10(3):763-7. PubMed ID: 6192767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes of anticancer activity and pulmonary toxicity of bleomycins in differences of administration schedules and routes in mice].
    Ekimoto H; Takahashi K; Matsuda A; Umezawa H
    Gan To Kagaku Ryoho; 1984 Apr; 11(4):853-7. PubMed ID: 6202241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Potentiation of the cytotoxic effects of various anticancer drugs by interferon on human neoplastic cells (HeLa) in culture].
    Namba M; Yamamoto S; Tanaka H; Kanamori T; Nobuhara M; Kimoto T
    Gan To Kagaku Ryoho; 1983 May; 10(5):1308-12. PubMed ID: 6191681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of aclacinomycin-A in head and neck cancer].
    Tsukuda M
    Gan To Kagaku Ryoho; 1984 Nov; 11(11):2335-41. PubMed ID: 6594077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental studies of new anthracyclines: aclacinomycin, THP-adriamycin and ditrisarubicins.
    Umezawa K; Kunimoto S; Takeuchi T
    Biomed Pharmacother; 1987; 41(5):206-13. PubMed ID: 2444279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Plasma concentration of peplomycin following intravenous infusion and subcutaneous infusion in patients with malignancies].
    Sampi K; Tari K; Kumai R; Satake I; Yashui H
    Gan To Kagaku Ryoho; 1984 Nov; 11(11):2372-4. PubMed ID: 6208851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of prostatic cancer by intramuscular administration and intratumor injection of peplomycin].
    Fujimoto Y; Okano M; Takeuchi T; Saito A; Fujihiro S; Kuriyama M; Sakai S; Nishiura T
    Hinyokika Kiyo; 1983 Nov; 29(11):1433-41. PubMed ID: 6203378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anthracycline dose intensity: clinical pharmacology and pharmacokinetics of high-dose doxorubicin administered as a 96-hour continuous intravenous infusion.
    Synold TW; Doroshow JH
    J Infus Chemother; 1996; 6(2):69-73. PubMed ID: 8809652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of single administration of tetrahydropyranyladriamycin (THP) in lymphoid malignancy].
    Takagi T; Oguro M; Iwabuchi K
    Gan To Kagaku Ryoho; 1984 Jul; 11(7):1450-6. PubMed ID: 6588924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticancer agents adsorbed by activated carbon particles, a new form of dosage enhancing efficacy on lymphnodal metastases.
    Hagiwara A; Ahn T; Ueda T; Iwamoto A; Ueda T; Torii T; Takahashi T
    Anticancer Res; 1986; 6(5):1005-8. PubMed ID: 2432828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antineoplastic drug-induced pneumonitis-fibrosis].
    Oizumi K; Nakai Y; Konno K
    Gan No Rinsho; 1984 Jul; 30(9 Suppl):1217-24. PubMed ID: 6206254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical phase I study of aclacinomycin A by evaluation of an intermittent intravenous administration schedule.
    Casper ES; Gralla RJ; Young CW
    Cancer Res; 1981 Jun; 41(6):2417-20. PubMed ID: 6940656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiotoxicity and comparative pharmacokinetics of six anthracyclines in the rabbit.
    Jaenke RS; Deprez-DeCampeneere D; Trouet A
    Cancer Res; 1980 Oct; 40(10):3530-6. PubMed ID: 6934026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of continuous subcutaneous injection of peplomycin based on its pharmakinetics].
    Fujii M; Inuyama I; Masuno S; Tanaka T; Takaoka T
    Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 1):1023-4. PubMed ID: 6191667
    [No Abstract]   [Full Text] [Related]  

  • 19. Feasibility and pharmacokinetic study of infusional dexrazoxane and dose-intensive doxorubicin administered concurrently over 96 h for the treatment of advanced malignancies.
    Chow WA; Synold TW; Tetef ML; Longmate J; Frankel P; Lawrence J; Al-Khadimi Z; Leong L; Lim D; Margolin K; Morgan RJ; Raschko J; Shibata S; Somlo G; Twardowski P; Yen Y; Doroshow JH
    Cancer Chemother Pharmacol; 2004 Sep; 54(3):241-8. PubMed ID: 15173955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intravesical instillation therapy of aclacinomycin-A (ACM) for superficial bladder tumor].
    Noguchi S; Kubota Y; Shuin T; Miura T; Moriyama M; Sakuramoto T; Oshima H
    Hinyokika Kiyo; 1984 Sep; 30(9):1153-8. PubMed ID: 6596878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.